Cargando…
SAT275 Generation And Characterization Of A Humanized CYP21A2 Mouse Model For Congenital Adrenal Hyperplasia
Disclosure: A. Huebner: None. S. Thirumalasetty: None. T. Schubert: None. R. Naumann: None. I. Reichardt: None. M. Rohm: None. D. Landgraf: None. F. Gembardt: None. M.F. Hartmann: None. S.A. Wudy: None. M. Peitzsch: None. N. Reisch: None. K. Koehler, PhD: None. 21-hydroxylase deficiency (21OHD) is t...
Autores principales: | Huebner, Angela, Thirumalasetty, Shamini Ramkumar, Schubert, Tina, Naumann, Ronald, Reichardt, Ilka, Rohm, Marie-Luise, Landgraf, Dana, Gembardt, Florian, Hartmann, Michaela F, Wudy, Stefan A, Peitzsch, Mirko, Reisch, Nicole, Koehler, Katrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553414/ http://dx.doi.org/10.1210/jendso/bvad114.280 |
Ejemplares similares
-
SAT303 High Frequency Of Stress Dose Adjustment And Adrenal Crisis In Adult Patients With Congenital Adrenal Hyperplasia
por: Tschaidse, Lea, et al.
Publicado: (2023) -
SAT282 Hypogonadism In Men With Congenital Adrenal Hyperplasia. A Retrospective Longitudinal Analysis With A Special Focus On Testicular Adrenal Rest Tumors And 11-oxygenated Androgens
por: Auer, Matthias K, et al.
Publicado: (2023) -
SAT297 Major Immunophenotypic Abnormalities In Patients With Primary Adrenal Insufficiency Of Different Etiology
por: Nowotny, Hanna Franziska, et al.
Publicado: (2023) -
SAT304 Improved Biochemical Control With Dose Reduction In Chronic Glucocorticoid Therapy: A Phase III Extension Study Of Chronocort (Efmody) In The Treatment Of Congenital Adrenal Hyperplasia (CAH)
por: Ross, Richard John M, et al.
Publicado: (2023) -
SAT290 Course of SARS-CoV-2 Infection In Patients With Congenital Adrenal Hyperplasia
por: Javaid, Rida, et al.
Publicado: (2023)